Friday, December 5, 2025
Search

Riot Blockchain And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Riot Blockchain  And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Riot Blockchain (RIOT), Renesola Ltd. (SOL), Chevron (CVX) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Riot Blockchain (RIOT)

411.3% sales growth and 3.72% return on equity

Riot Blockchain's sales growth this year is expected to be 1726.8% and 115.3% for next year.

Year-on-year quarterly revenue growth grew by 2532.3%, now sitting on 127.64M for the twelve trailing months.

Volume

Today's last reported volume for Riot Blockchain is 7269160 which is 16.76% below its average volume of 8733160.

Riot Blockchain's sales growth for the next quarter is 411.3%. The company's growth estimates for the ongoing quarter and the next is 212.5% and 444.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.72%.

Volatility

Riot Blockchain's last day, last week, and last month's current intraday variation average was 6.87%, 8.80%, and 9.41%, respectively.

Riot Blockchain's highest amplitude of average volatility was 19.20% (day), 18.61% (last week), and 14.94% (last month), respectively.

Riot Blockchain's Stock Yearly Top and Bottom Value

Riot Blockchain's stock is valued at $8.19 at 11:22 EST, way under its 52-week low of $10.11.

Riot Blockchain's Moving Average

Riot Blockchain's worth is way below its 50-day moving average of $16.69 and way below its 200-day moving average of $25.28.

Previous days news about Riot Blockchain(RIOT)

  • According to MarketWatch on Monday, 9 May, "Crypto plays in the stock market tumbled in premarket trade after weekend trading left bitcoin shares fell more than 4%, as MicroStrategy and Riot Blockchain each fell more than 6%. "

2. Renesola Ltd. (SOL)

50.1% sales growth and 3.38% return on equity

Through its subsidiaries, ReneSola Ltd develops, constructs, operates and sells solar energy projects in Europe and the United States.

Renesola Ltd.'s sales growth this year is expected to be 39.5% and 21.9% for next year.

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 73.25M for the twelve trailing months.

Volume

Today's last reported volume for Renesola Ltd. is 485037 which is 56.29% below its average volume of 1109720.

Renesola Ltd.'s sales growth for the next quarter is 50.1%. The company's growth estimates for the current quarter and the next is a negative 600% and negative -70%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.38%.

Volatility

Renesola Ltd.'s last day, last week, and last month's current intraday variation average was 2.34%, 2.54%, and 2.90%, respectively.

Renesola Ltd.'s highest amplitude of average volatility was 6.15% (day), 5.97% (last week), and 5.85% (last month), respectively.

Renesola Ltd.'s Stock Yearly Top and Bottom Value

Renesola Ltd.'s stock is valued at $4.71 at 11:22 EST, way under its 52-week high of $10.70 and above its 52-week low of $4.53.

Renesola Ltd.'s Moving Average

Renesola Ltd.'s value is way below its 50-day moving average of $5.79 and way below its 200-day moving average of $6.53.

3. Chevron (CVX)

33.3% sales growth and 11.65% return on equity

Through its subsidiaries, Chevron Corporation engages in integrated oil, chemical, and petroleum operations around the world.

Chevron's sales growth this year is expected to be 66.6% and 9.6% for next year.

Year-on-year quarterly revenue growth grew by 84.6%, now sitting on 155.61B for the twelve trailing months.

Volume

Today's last reported volume for Chevron is 2746070 which is 82.82% below its average volume of 15986400.

Chevron's sales growth for the next quarter is 33.3%. The company's growth estimates for the present quarter and the next is 30400% and 177.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.65%.

Volatility

Chevron's last day, last week, and last month's current intraday variation average was 0.05%, 2.55%, and 1.92%, respectively.

Chevron's highest amplitude of average volatility was 4.28% (day), 4.71% (last week), and 3.42% (last month), respectively.

Chevron's Stock Yearly Top and Bottom Value

Chevron's stock is valued at $167.67 at 11:22 EST, below its 52-week high of $174.76 and way higher than its 52-week low of $92.86.

Chevron's Moving Average

Chevron's worth is higher than its 50-day moving average of $163.37 and way above its 200-day moving average of $125.74.

4. REGENXBIO (RGNX)

27.6% sales growth and 22.39% return on equity

REGENXBIO Inc. is a biotechnology company in clinical stage that offers gene therapy products to help cells overcome genetic disorders or produce therapeutic antibodies or proteins to treat disease.

REGENXBIO's sales growth this year is expected to be 113.1% and a negative 43.9% for next year.

Year-on-year quarterly revenue growth grew by 1759%, now sitting on 470.35M for the twelve trailing months.

Volume

Today's last reported volume for REGENXBIO is 322515 which is 21.73% below its average volume of 412085.

REGENXBIO's sales growth for the next quarter is 27.6%. The company's growth estimates for the current quarter and the next is 479.8% and negative -10%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.39%.

Volatility

REGENXBIO's last day, last week, and last month's current intraday variation average was 4.45%, 2.43%, and 2.35%, respectively.

REGENXBIO's highest amplitude of average volatility was 6.27% (day), 5.11% (last week), and 4.74% (last month), respectively.

REGENXBIO's Stock Yearly Top and Bottom Value

REGENXBIO's stock is valued at $28.01 at 11:22 EST, way under its 52-week high of $46.46 and way above its 52-week low of $24.09.

REGENXBIO's Moving Average

REGENXBIO's worth is under its 50-day moving average of $29.37 and way under its 200-day moving average of $32.34.

5. Ryder System (R)

15.5% sales growth and 20.64% return on equity

Ryder System, Inc. offers transportation and supply chain management services worldwide.

Ryder System's sales growth this year is anticipated to be 19% and 4.6% for next year.

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 9.66B for the twelve trailing months.

Volume

Today's last reported volume for Ryder System is 850840 which is 15.39% above its average volume of 737320.

Ryder System's sales growth for the next quarter is 15.5%. The company's growth estimates for the ongoing quarter and the next is 54.2% and 29.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.64%.

Volatility

Ryder System's last day, last week, and last month's current intraday variation average was 1.65%, 1.98%, and 2.28%, respectively.

Ryder System's highest amplitude of average volatility was 3.96% (day), 4.39% (last week), and 4.12% (last month), respectively.

Ryder System's Stock Yearly Top and Bottom Value

Ryder System's stock is valued at $71.05 at 11:22 EST, way under its 52-week high of $93.05 and way above its 52-week low of $61.71.

Ryder System's Moving Average

Ryder System's worth is below its 50-day moving average of $74.66 and under its 200-day moving average of $78.60.

6. Washington Federal (WAFD)

14.3% sales growth and 8.81% return on equity

Washington Federal, Inc. is the bank holding firm for Washington Federal Bank, National Association. It provides banking services, including insurance, lending, deposit, and depository, in the United States.

Washington Federal's sales growth this year is anticipated to be 11.4% and 12.7% for next year.

Year-on-year quarterly revenue growth declined by 0.7%, now sitting on 598.84M for the twelve trailing months.

Volume

Today's last reported volume for Washington Federal is 365863 which is 17.66% below its average volume of 444365.

Washington Federal's sales growth for the next quarter is 14.3%. The company's growth estimates for the current quarter and the next is 26.2% and 18.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.81%.

Volatility

Washington Federal's last day, last week, and last month's current intraday variation average was 0.71%, 1.63%, and 1.44%, respectively.

Washington Federal's highest amplitude of average volatility was 2.38% (day), 2.85% (last week), and 2.65% (last month), respectively.

Washington Federal's Stock Yearly Top and Bottom Value

Washington Federal's stock is valued at $30.87 at 11:22 EST, way below its 52-week high of $38.06 and higher than its 52-week low of $29.01.

Washington Federal's Moving Average

Washington Federal's value is under its 50-day moving average of $32.99 and below its 200-day moving average of $33.93.

7. The First of Long Island Corporation (FLIC)

6.5% sales growth and 11.01% return on equity

The First of Long Island Corporation is the holding company of The First National Bank of Long Island, which provides financial services for small- and medium-sized companies, professionals, residents, and municipalities.

The First of Long Island Corporation's sales growth this year is anticipated to be 5.1% and 3.1% for next year.

Year-on-year quarterly revenue growth grew by 1.9%, now sitting on 122.53M for the twelve trailing months.

Volume

Today's last reported volume for The First of Long Island Corporation is 63547 which is 9.68% above its average volume of 57934.

The First of Long Island Corporation's sales growth for the next quarter is 6.5%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.01%.

Volatility

The First of Long Island Corporation's last day, last week, and last month's current intraday variation average was 0.72%, 3.81%, and 1.65%, respectively.

The First of Long Island Corporation's highest amplitude of average volatility was 2.93% (day), 4.37% (last week), and 2.54% (last month), respectively.

The First of Long Island Corporation's Stock Yearly Top and Bottom Value

The First of Long Island Corporation's stock is valued at $18.00 at 11:22 EST, way under its 52-week high of $23.98 and above its 52-week low of $16.51.

The First of Long Island Corporation's Moving Average

The First of Long Island Corporation's worth is below its 50-day moving average of $19.89 and way below its 200-day moving average of $20.98.

8. Equifax (EFX)

5.9% sales growth and 21.56% return on equity

Equifax Inc. offers information solutions, human resource business process outsourcing and other services to businesses, governments and consumers.

Equifax's sales growth this year is expected to be 16.7% and 6.3% for next year.

Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 4.79B for the twelve trailing months.

Volume

Today's last reported volume for Equifax is 210408 which is 82.14% below its average volume of 1178740.

Equifax's sales growth for the next quarter is 5.9%. The company's growth estimates for the current quarter and the next is a negative 8% and negative -11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.56%.

Volatility

Equifax's last day, last week, and last month's current intraday variation average was 0.57%, 2.19%, and 2.24%, respectively.

Equifax's highest amplitude of average volatility was 2.21% (day), 3.00% (last week), and 3.60% (last month), respectively.

Equifax's Stock Yearly Top and Bottom Value

Equifax's stock is valued at $197.74 at 11:22 EST, way under its 52-week high of $296.63 and way above its 52-week low of $161.87.

Equifax's Moving Average

Equifax's value is way below its 50-day moving average of $275.65 and way under its 200-day moving average of $242.45.